Sanghyuk Chung to Uterine Cervical Neoplasms
This is a "connection" page, showing publications Sanghyuk Chung has written about Uterine Cervical Neoplasms.
Connection Strength
6.084
-
Functional roles of female sex hormones and their nuclear receptors in cervical cancer. Essays Biochem. 2021 12 17; 65(6):941-950.
Score: 0.748
-
Estrogen Inhibits Epithelial Progesterone Receptor-Dependent Progestin Therapy Efficacy in a Mouse Model of Cervical Cancer. Am J Pathol. 2022 02; 192(2):353-360.
Score: 0.743
-
Non-Metabolic Functions of PKM2 Contribute to Cervical Cancer Cell Proliferation Induced by the HPV16 E7 Oncoprotein. Viruses. 2021 03 08; 13(3).
Score: 0.709
-
Progesterone Receptor Is a Haploinsufficient Tumor-Suppressor Gene in Cervical Cancer. Mol Cancer Res. 2021 01; 19(1):42-47.
Score: 0.692
-
Medroxyprogesterone Acetate Prevention of Cervical Cancer through Progesterone Receptor in a Human Papillomavirus Transgenic Mouse Model. Am J Pathol. 2019 12; 189(12):2459-2468.
Score: 0.647
-
Epithelial oestrogen receptor a is dispensable for the development of oestrogen-induced cervical neoplastic diseases. J Pathol. 2018 06; 245(2):147-152.
Score: 0.579
-
Recurrence of cervical cancer and its resistance to progestin therapy in a mouse model. Oncotarget. 2017 Jan 10; 8(2):2372-2380.
Score: 0.532
-
Targeting female hormone receptors as cervical cancer therapy. Trends Endocrinol Metab. 2015 Aug; 26(8):399-401.
Score: 0.479
-
Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice. Carcinogenesis. 2014 Feb; 35(2):489-96.
Score: 0.425
-
Progesterone signaling inhibits cervical carcinogenesis in mice. Am J Pathol. 2013 Nov; 183(5):1679-1687.
Score: 0.421
-
Recurrence of cervical cancer in mice after selective estrogen receptor modulator therapy. Am J Pathol. 2014 Feb; 184(2):530-40.
Score: 0.108